NYSE · CHEMICALS & ALLIED PRODUCTS · LARGE CAP
Olin Corp. OLN
18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$6.8B
▲ 3.7% vs FY2024
EPS · FY25
$-0.88
Dividend / sh · FY25
—
Payout · FY25
-91%
ROE · FY25
-5.2%
Net margin · FY25
-1.5%
Dividend coverage
-7.7×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 6.8B
Revenue, FY2025 · full 18-year series below
Revenue
Net income
The company lost 1 cents on every revenue dollar this year.
Per share
USD -0.88
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
-5.2%
Return on equity, FY2025
ROE
Operating margin0.1%
Net margin-1.5%
Return on assets-1.4%
Each USD of equity lost 5 cents this year.
Returned to shareholders
USD 139.8M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 91.6M
Net buybacksUSD 48.2M
Share of profit-138.3%
Consecutive raises—
USD 91.6M in dividends and USD 48.2M in buybacks went back to shareholders in a year without profit.
Growth
+3.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−10.2%
+3.3%
+9.0%
+10.2%
Dividend / share
+0.0%
+0.0%
Returned to shareholders
−54.1%
+2.1%
+5.8%
+5.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.11B
Shares outstanding, FY2025
Change, 5 years−28.1%
Change, 10 years−31.2%
The share count shrank 28% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 7.3B
total assets, end of FY2025
Total assetsUSD 7.3B
EquityUSD 1.8B
CashUSD 167.6M
Gross debtUSD 2.8B
Net debtUSD 2.7B
Current ratio1.21×
Net debt stands at 145% of equity.
History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
6.8
6.5
6.8
9.4
8.9
5.8
6.1
6.9
6.3
5.6
2.9
2.2
2.5
2.2
2.0
1.6
1.5
1.8
Operating income $B
0.0
0.3
0.7
1.8
1.9
−0.7
0.2
0.7
0.3
0.1
0.1
0.2
0.3
0.3
0.2
0.1
0.2
0.3
EBITDA $B
0.5
0.8
1.2
2.4
2.4
−0.2
0.8
1.3
0.9
0.6
0.3
0.3
0.4
0.4
0.3
0.2
0.3
0.3
Income tax $B
−0.1
0.0
0.1
0.3
0.2
−0.1
−0.0
0.1
−0.4
−0.0
0.0
0.1
0.1
0.1
0.1
0.0
0.1
0.1
Net income $B
−0.1
0.1
0.5
1.3
1.3
−1.0
−0.0
0.3
0.5
−0.0
−0.0
0.1
0.2
0.1
0.2
0.1
0.1
0.2
EPS, diluted $
−0.88
0.91
3.57
8.94
7.96
−6.14
−0.07
1.95
3.26
−0.02
−0.01
1.33
2.21
1.85
2.99
0.81
1.73
2.07
Dividend / sh $
·
·
·
·
·
0.80
0.80
0.80
0.80
0.80
0.80
0.80
0.80
0.80
0.80
0.80
0.80
0.80
Payout %
−91
90
22
9
10
−13
−1144
41
24
−3387
−5679
60
36
43
26
98
46
38
ROE %
−5.2
4.9
18.9
51.1
63.2
−50.1
−0.4
11.7
21.9
−0.2
−0.1
10.0
17.0
15.1
26.6
7.8
17.8
22.4
Shares out B
0.11
0.12
0.12
0.13
0.16
0.16
0.16
0.17
0.17
0.17
0.17
0.08
0.08
0.08
0.08
0.08
0.08
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
56 of 56
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed